Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00068809 · ClinicalTrials.gov registry record · Phase 4
4-Day-A-Week Treatment Plan for HIV Infected Adolescents
A Phase 4 study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- Phase 4
- Development phase
- 31
- Enrollment target
NCT00068809 is a Phase 4 study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 31 participants.
The verdict
NCT00068809, a Phase 4 study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 31 participants
- Enrollment target
Study Summary
This study will determine if taking anti-HIV drugs 4 days a week will control HIV-1 viral replication in patients who have already had at least 6 months of documented viral suppression with full-time treatment. If this strategy is shown to be safe in this study, a larger study will be undertaken to determine if the strategy can decrease overall drug exposure and help young people adjust more easily to a chronic medication schedule.
Interventions
- PROCEDURE Short Cycle Antiretroviral Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2003-07 |
| Est. Completion | 2007-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00068809
The ClinicalTrials.gov registry entry for NCT00068809 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Short Cycle Antiretroviral Therapy is the first listed.
NCT00068809 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00068809 about?
NCT00068809 is a clinical study titled "4-Day-A-Week Treatment Plan for HIV Infected Adolescents". This study will determine if taking anti-HIV drugs 4 days a week will control HIV-1 viral replication in patients who have already had at least 6 months of documented viral suppression with full-time treatment. If this strategy is shown to be safe in this study, a larger study will be undertaken to ...
What is the current status of trial NCT00068809?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 31 participants. The study started on 2003-07. Estimated completion is 2007-01.
What interventions are being tested in trial NCT00068809?
The interventions under investigation include: Short Cycle Antiretroviral Therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00068809?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.